Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition.

Fas exon 6 can be included or skipped to generate mRNAs encoding, respectively, a membrane bound form of the receptor that promotes apoptosis or a soluble isoform that prevents programmed cell death. We report that the apoptosis-inducing protein TIA-1 promotes U1 snRNP binding to the 5' splice site of intron 6, which in turn facilitates exon definition by enhancing U2AF binding to the 3' splice site of intron 5. The polypyrimidine tract binding protein (PTB) promotes exon skipping by binding to an exonic splicing silencer and inhibiting the association of U2AF and U2 snRNP with the upstream 3' splice site, without affecting recognition of the downstream 5' splice site by U1. Remarkably, U1 snRNP-mediated recognition of the 5' splice site is required both for efficient U2AF binding and for U2AF inhibition by PTB. We propose that TIA-1 and PTB regulate Fas splicing and possibly Fas-mediated apoptosis by targeting molecular events that lead to exon definition.

[1]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[2]  J. G. Patton,et al.  Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. , 1991, Genes & development.

[3]  J. Mountz,et al.  Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. , 1995, The Biochemical journal.

[4]  T. Cooper,et al.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. , 2003, RNA.

[5]  P. Sharp,et al.  Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns. , 1989, Genes & development.

[6]  S. Berget.  Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.

[7]  N. Kedersha,et al.  Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus‐induced apoptosis , 2002, The EMBO journal.

[8]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[9]  Tom Maniatis,et al.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing , 1993, Cell.

[10]  M. Blanchette,et al.  Modulation of exon skipping by high‐affinity hnRNP A1‐binding sites and by intron elements that repress splice site utilization , 1999, The EMBO journal.

[11]  Michael R. Green,et al.  Cloning and domain structure of the mammalian splicing factor U2AF , 1992, Nature.

[12]  C. H. Lin,et al.  Regulation of alternative 3' splice site selection by constitutive splicing factors. , 1995, RNA.

[13]  D. Baralle,et al.  hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes. , 2004, Nucleic acids research.

[14]  C. Gooding,et al.  The PTB interacting protein raver1 regulates α‐tropomyosin alternative splicing , 2003 .

[15]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[16]  T. Cooper,et al.  Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. , 2002, Molecular cell.

[17]  J. Valcárcel,et al.  The splicing regulator TIA‐1 interacts with U1‐C to promote U1 snRNP recruitment to 5′ splice sites , 2002, The EMBO journal.

[18]  O. Kent,et al.  Characterization of a U2AF-Independent Commitment Complex (E′) in the Mammalian Spliceosome Assembly Pathway , 2005, Molecular and Cellular Biology.

[19]  A. Plet,et al.  Polypyrimidine Tract-binding Protein Represses Splicing of a Fibroblast Growth Factor Receptor-2 Gene Alternative Exon through Exon Sequences* , 2001, The Journal of Biological Chemistry.

[20]  J. Stévenin,et al.  TIA-1 and TIAR Activate Splicing of Alternative Exons with Weak 5′ Splice Sites followed by a U-rich Stretch on Their Own Pre-mRNAs* , 2001, The Journal of Biological Chemistry.

[21]  H. Lou,et al.  U1 snRNP-Dependent Function of TIAR in the Regulation of Alternative RNA Processing of the Human Calcitonin/CGRP Pre-mRNA , 2003, Molecular and Cellular Biology.

[22]  E. Buratti,et al.  An Intronic Polypyrimidine-rich Element Downstream of the Donor Site Modulates Cystic Fibrosis Transmembrane Conductance Regulator Exon 9 Alternative Splicing* , 2004, Journal of Biological Chemistry.

[23]  E. Wagner,et al.  RNAi-mediated PTB depletion leads to enhanced exon definition. , 2002, Molecular cell.

[24]  D. Black,et al.  Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.

[25]  J. Stévenin,et al.  The RNA-Binding Protein TIA-1 Is a Novel Mammalian Splicing Regulator Acting through Intron Sequences Adjacent to a 5′ Splice Site , 2000, Molecular and Cellular Biology.

[26]  P. Grabowski,et al.  Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. , 1991, Science.

[27]  Douglas L Black,et al.  Exon repression by polypyrimidine tract binding protein. , 2005, RNA.

[28]  Michael R Green,et al.  A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2. , 2004, RNA.

[29]  Paul Anderson,et al.  A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells , 1991, Cell.

[30]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[31]  Douglas L. Black,et al.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex. , 2005, Molecular cell.

[32]  P. Schedl,et al.  Sex-lethal interacts with splicing factors in vitro and in vivo , 1996, Molecular and cellular biology.

[33]  A. Krainer,et al.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. , 2001, Molecular cell.

[34]  J. Valcárcel,et al.  Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. , 1995, Science.

[35]  M. Ashiya,et al.  A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. , 1997, RNA.

[36]  P. Anderson,et al.  Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. , 1996, Nucleic acids research.

[37]  J. Valcárcel,et al.  Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3′ splice site AG , 1999, Nature.

[38]  E. Wagner,et al.  Polypyrimidine Tract Binding Protein Antagonizes Exon Definition , 2001, Molecular and Cellular Biology.

[39]  D L Black,et al.  Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. , 2000, Molecular cell.

[40]  J. Valcárcel,et al.  The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. , 2000, Molecular cell.

[41]  M. Streuli,et al.  Identification and functional characterization of a TIA-1-related nucleolysin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Fiucci,et al.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.

[43]  M. Rosbash,et al.  Cross-Intron Bridging Interactions in the Yeast Commitment Complex Are Conserved in Mammals , 1997, Cell.

[44]  M. Huynen,et al.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Dember,et al.  Individual RNA Recognition Motifs of TIA-1 and TIAR Have Different RNA Binding Specificities (*) , 1996, The Journal of Biological Chemistry.